Condition: Atypical Endometrial Hyperplasia · Fertility Issues · Overweight and Obesity · Sponsor: Xiaojun Chen
To investigate the efficacy of weight management plus levonorgestrel intrauterine system (LNG-IUS) or megestrol acetate (MA) in obese patients with endometrial atypical hyperplasia (EAH) asking for conservative therapy.
This description comes directly from the study's public registry record.
WEIWEI SHAN, PhD · 8613817813106 · danweiwei7468@fckyy.org.cn
XIAOJUN CHEN, PhD · 8613601680784 · cxjlhjj@163.com
Always discuss trial participation with your own doctor first.
| Obstetrics and Gynecology Hospital of Fudan University | Shanghai, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05316493